TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Emergency care visits due to worsening of COVID-19
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Need for hospitalization due to COVID-19 progression
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SPO2 ≤ 93% after randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Levodopa and Carbidopa: area under the plasma concentration-time curve from 0 to time t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Levodopa and Carbidopa: area under the plasma concentration-time curve from 0 to time t (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Levodopa and Carbidopa: Maximum plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Levodopa and Carbidopa: Time to achieve maximum plasma concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of Prostatic Carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: change of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine IL10 levels in peritoneal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concordance of nutritional recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pharmacokinetic (PK) Plasma Concentrations of Enpatoran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm birth prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cumulative incidences of relapse (CIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cross-sectional area of the quadriceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cross-sectional area of the hamstrings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak flexion and extension knee torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Average flexion and extension knee torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Flexion and extension knee work
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Level of Shared Decision Making (SDM) adoption
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Psycho-behavioral profile
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weekly Heartburn Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PRAE incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ultrasound score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of Temferon-derived progeny in the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Serum Uric Acid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Range of active knee joint flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants with Abnormal Laboratory Parameters Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autism Spectrum Quotient (AQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Friendship Quality Scale (FQS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pelvic floor muscle displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of IANBD based on number of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of IANBD based on type of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Leukotriene concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Medical Adhesive-Related Skin Injury (MARSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-reported pain scores during drape removal
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in medication use for anxiety, pain, and stress
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: successful sedation ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body fat distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pregnancy rates after intervention
Endpoint domain: Life impact
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of patients achieving HbA1c target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients achieving blood pressure target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients achieving LDL-cholesterol target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Pure Tone Audiometry for Hearing Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Speech Discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tinnitus Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants initiating hepatitis C treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants who achieve SVR following hepatitis C treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparative cost and cost-effectiveness of care models
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in blood ketones levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrent laryngeal nerve injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Parathyroid gland Injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Intraoperative injury to trachea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence of residual or recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall Survival - Mortality Hazard Ratio
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival - Mortality Risk
Endpoint domain: Mortality/survival
Primary endpoint: perinatal morbidity-mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Positive Histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fluorescent intensity contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDR s-III: Unified Parkinson's Disease Rating Scale-Motor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: The time up and go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-related adverse events and complications
Endpoint domain: Adverse events/effects
Primary endpoint: EORTC QLQ-C30 score for overall quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cohen Mansfield Agitation Inventory (CMAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Resting arm angle (RANG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analogue Scale (VAS) of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in The McGill Pain Questionnaire (SF-MQ2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Algometer pain pressure threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cellular response to vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bone resorption marker sCTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Life Using SF-36 Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Time to Clinical Recovery (TTCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to no oozing/hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in fatigue from baseline to post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in sleep quality from baseline to post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Laboratory tests findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right ventricular-arterial coupling (RVAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vascular Endothelial Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of Participants in Cohort 1a Who Experience at Least One Grade 3 or Higher Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants in Cohort 1b Who Experience at Least One Grade 3 or Higher Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change in Immunoglobulin G4-Related Disease Responder Index (IgG4-RD RI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Skin Tissue versus Serum Concentration Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Colon Tissue versus Serum Concentration Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Synovial Tissue versus Serum Concentration Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in response to deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to complete the recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: participants' satisfaction and perspectives of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DRSS severity progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to vision-threatening complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Drooling frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle joint range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle joint strength test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antral Follicle Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Stability of NIS4 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary haemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Secondary haemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Global Impression scales of Severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total knee temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature of the knee regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Tegner Activity Level Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IKDC-Subjective Score (Subjective International Knee Documentation Committee)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective parameters - Circumferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective parameters- Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the tumor microenvironment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: OSA self-efficacy using the SEMSA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PAP usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Alignment of Cxbladder Detect-plus results with standard of care diagnostic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of host-derived biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tenofovir diphosphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adoption of the integrated care model
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptability of the integrated care model
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the integrated care model
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Fidelity of the integrated care model
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Increase in plasmatic concentration of pantothenic acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk factor assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response delay time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep spindle density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events associated with the DT-PLB intervention
Endpoint domain: Adverse events/effects
Primary endpoint: EIM phase change over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in clinically assessed local skin responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prognosis
Endpoint domain: Mortality/survival
Primary endpoint: Treatment acceptability/usefulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absence of a serious medical complication (SMC)
Endpoint domain: Mortality/survival
Primary endpoint: Complete closure of the fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of questionnaire PRO
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peri implant bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keratinized tissues level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with dyslipidemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with Diabetic kidney disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of participants with Coronary heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with thyroid disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participants with Stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SPID48 (sum of pain intensity difference at 48 hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Content Completion Rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in response to Brief Pain Inventory (BPI)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in response to FACT-G
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in response to EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Job Search Behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in the reflective total nasal symptom score (rTNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of strabismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biofluids concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence, nature, and severity of adverse events and laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Urea synthesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thickness of the quadriceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adverse events associated with the Enolen implant
Endpoint domain: Adverse events/effects
Primary endpoint: Success of identifying the sentinel lymph node (SLN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Doravirine area under the plasma concentration versus time curve from 0 hours to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doravirine maximum concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doravirine trough concentration (C24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NCT-CTCAE peripheral neuropathy grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brief Pain Inventory Short Form (BPI-SF) Bworst pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Knee joint stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal survival without surgical intervention
Endpoint domain: Mortality/survival
Primary endpoint: oral frailty measures (oral functions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral odor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral dynamics of influenza, RSV and SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from onset of stroke until alarm by the device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain perception level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: stress perception level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anxiety perception level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amplitude and spectrum of global evoked auditory nerve activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ethinylestradiol plasma concentration time curve at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Levonorgestrel plasma concentration time curve at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Neural activity of the anterior insula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: overall weight of women incarcerated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall BMI trends of women incarcerated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of non-cardiac chest pain (NCCP) patients admitted at the cardiac ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of hair changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased caspase-3 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes